Cystic fibrosis: Translating molecular mechanisms into effective therapies

Mark T. Jennings, Patrick A. Flume

Research output: Contribution to journalReview articlepeer-review

Abstract

Cystic fibrosis is a genetic disease that affects approximately 75,00 individuals around the world. Long regarded as a lethal and life-limiting disease, with the most severe manifestations expressed in the progressive decline of lung function, treatment advances focusing on airway clearance and management of chronic lung infection have resulted in improved outcomes for individuals wit cystic fibrosis. These advances have been realized in conjunction with an improved understanding of the genetic basis of this disease dating back to the discovery of the cystic fibrosis gene in 1989. Th identification of the cystic fibrosis gene and the advancement of our understanding of the resultant cystic fibrosis transmembrane conductance regulator protein have led to the development of a new class of cystic fibrosis therapies designed to directly impact the function of this protein. These therapeutic developments have progressed, targeting the various mutations that can cause cystic fibrosis. These new medications, known as cystic fibrosis transmembrane conductance regulator modulators, have changed the landscape of cystic fibrosis care and cystic fibrosis research. Their demonstrated effect in patients with specific cystic fibrosis mutations has ignited the hope that such therapies will soon be available to more individuals with this disease, moving the cystic fibrosis community significantly closer to the ultimate goal of curing this disease.

Original languageEnglish (US)
Pages (from-to)897-902
Number of pages6
JournalAnnals of the American Thoracic Society
Volume15
Issue number8
DOIs
StatePublished - Aug 2018

Keywords

  • CFTR
  • Cystic fibrosis
  • Drug development

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Cystic fibrosis: Translating molecular mechanisms into effective therapies'. Together they form a unique fingerprint.

Cite this